Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Congenital goitrous hypothyroidism is caused by dysfunction of the iodide transporter SLC26A7.

Ishii J, Suzuki A, Kimura T, Tateyama M, Tanaka T, Yazawa T, Arimasu Y, Chen IS, Aoyama K, Kubo Y, Saitoh S, Mizuno H, Kamma H.

Commun Biol. 2019 Jul 24;2:270. doi: 10.1038/s42003-019-0503-6. eCollection 2019.

2.

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan.

Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Mori M, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Ito H, Higuchi I, Hashiguchi A, Nodera H, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M.

Orphanet J Rare Dis. 2019 Jun 26;14(1):155. doi: 10.1186/s13023-019-1122-5.

3.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
4.

Non-sedating antihistamines block G-protein-gated inwardly rectifying K+ channels.

Chen IS, Liu C, Tateyama M, Karbat I, Uesugi M, Reuveny E, Kubo Y.

Br J Pharmacol. 2019 Sep;176(17):3161-3179. doi: 10.1111/bph.14717. Epub 2019 Jul 10.

PMID:
31116876
5.

FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis.

Nakamura N, Izumi R, Hoshi Y, Takai Y, Ono R, Suzuki N, Nagai T, Ishii Y, Ishii T, Harigae H, Okada S, Aiba S, Okiyama N, Fujimoto M, Kuroda H, Tateyama M, Aoki M.

Rheumatology (Oxford). 2019 Mar 16. pii: kez083. doi: 10.1093/rheumatology/kez083. [Epub ahead of print] No abstract available.

PMID:
30879053
6.

A Computed Tomographic Assessment of Tracheostomy Tube Placement in Patients with Chronic Neurological Disorders: The Prevention of Tracheoarterial Fistula.

Tateyama M, Konno M, Takano R, Chida K, Rikimaru H, Chida K.

Intern Med. 2019 May 1;58(9):1251-1256. doi: 10.2169/internalmedicine.1158-18. Epub 2019 Jan 10.

7.

SLO potassium channels antagonize premature decision making in C. elegans.

Aoki I, Tateyama M, Shimomura T, Ihara K, Kubo Y, Nakano S, Mori I.

Commun Biol. 2018 Aug 24;1:123. doi: 10.1038/s42003-018-0124-5. eCollection 2018.

8.

Gi/o-coupled muscarinic receptors co-localize with GIRK channel for efficient channel activation.

Tateyama M, Kubo Y.

PLoS One. 2018 Sep 21;13(9):e0204447. doi: 10.1371/journal.pone.0204447. eCollection 2018.

9.

Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis.

Kawaguchi N, Izumi R, Kobayashi M, Tateyama M, Suzuki N, Fujishima F, Fujimori J, Aoki M, Nakashima I.

Intern Med. 2019 Jan 15;58(2):277-282. doi: 10.2169/internalmedicine.0859-18. Epub 2018 Aug 24.

10.

Two mutations at different positions in the CNBH domain of the hERG channel accelerate deactivation and impair the interaction with the EAG domain.

Kume S, Shimomura T, Tateyama M, Kubo Y.

J Physiol. 2018 Oct;596(19):4629-4650. doi: 10.1113/JP276208. Epub 2018 Sep 3.

PMID:
30086184
11.

New Genetically Manipulated Mice Provide Insights Into the Development and Physiological Functions of Invariant Natural Killer T Cells.

Ren Y, Sekine-Kondo E, Tateyama M, Kasetthat T, Wongratanacheewin S, Watarai H.

Front Immunol. 2018 Jun 14;9:1294. doi: 10.3389/fimmu.2018.01294. eCollection 2018. Review.

12.

Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.

Kami-Onaga K, Tateyama M, Kinjo T, Parrott G, Tominaga D, Takahashi-Nakazato A, Nakamura H, Tasato D, Miyagi K, Maeda S, Arae H, Uehara H, Miyagi K, Haranaga S, Fujita J.

PLoS One. 2018 Jun 14;13(6):e0199106. doi: 10.1371/journal.pone.0199106. eCollection 2018.

13.

Clinical Features of Human Metapneumovirus Pneumonia in Non-Immunocompromised Patients: An Investigation of Three Long-Term Care Facility Outbreaks.

Karimata Y, Kinjo T, Parrott G, Uehara A, Nabeya D, Haranaga S, Higa F, Tateyama M, Miyagawa K, Kishaba T, Otani K, Okamoto M, Nishimura H, Fujita J.

J Infect Dis. 2018 Aug 14;218(6):868-875. doi: 10.1093/infdis/jiy261.

PMID:
29733351
14.

Activation of AMPK-Regulated CRH Neurons in the PVH is Sufficient and Necessary to Induce Dietary Preference for Carbohydrate over Fat.

Okamoto S, Sato T, Tateyama M, Kageyama H, Maejima Y, Nakata M, Hirako S, Matsuo T, Kyaw S, Shiuchi T, Toda C, Sedbazar U, Saito K, Asgar NF, Zhang B, Yokota S, Kobayashi K, Foufelle F, Ferré P, Nakazato M, Masuzaki H, Shioda S, Yada T, Kahn BB, Minokoshi Y.

Cell Rep. 2018 Jan 16;22(3):706-721. doi: 10.1016/j.celrep.2017.11.102.

15.

Do infections with disseminated Mycobacterium avium complex precede sweet's syndrome? A case report and literature review.

Hibiya K, Miyagi K, Tamayose M, Nabeya D, Kinjo T, Takeshima S, Ikemiyagi N, Yamada K, Fujita A, Hashioka H, Kami W, Inamine M, Shibahara D, Nakamura H, Furugen M, Haranaga S, Higa F, Tateyama M, Fujita J.

Int J Mycobacteriol. 2017 Oct-Dec;6(4):336-343. doi: 10.4103/ijmy.ijmy_172_17. Review.

16.

Five-year history of dysphagia as a sole initial symptom in inclusion body myositis.

Shibata S, Izumi R, Hara T, Ohshima R, Nakamura N, Suzuki N, Kato K, Katori Y, Tateyama M, Kuroda H, Aoki M.

J Neurol Sci. 2017 Oct 15;381:325-327. doi: 10.1016/j.jns.2017.09.014. Epub 2017 Sep 12. No abstract available.

PMID:
28991709
17.

Evaluation of Anyplex™ II RV16 and RB5 real-time RT-PCR compared to Seeplex® RV15 OneStep ACE and PneumoBacter ACE for the simultaneous detection of upper respiratory pathogens.

Parrott G, Kinjo T, Nabeya D, Uehara A, Nahar S, Miyagi K, Haranaga S, Tateyama M, Fujita J.

J Infect Chemother. 2017 Dec;23(12):859-861. doi: 10.1016/j.jiac.2017.07.013. Epub 2017 Aug 19.

PMID:
28830668
18.

Ivermectin activates GIRK channels in a PIP2 -dependent, Gβγ -independent manner and an amino acid residue at the slide helix governs the activation.

Chen IS, Tateyama M, Fukata Y, Uesugi M, Kubo Y.

J Physiol. 2017 Sep 1;595(17):5895-5912. doi: 10.1113/JP274871. Epub 2017 Jul 30.

19.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2017 Sep;23(9):587-597. doi: 10.1016/j.jiac.2017.05.010. Epub 2017 Jun 29.

PMID:
28669567
20.

Combination of large-volume sample stacking with an electroosmotic flow pump with field-amplified sample injection on cross-channel chips.

Kitagawa F, Ishiguro T, Tateyama M, Nukatsuka I, Sueyoshi K, Kawai T, Otsuka K.

Electrophoresis. 2017 Aug;38(16):2075-2080. doi: 10.1002/elps.201700155. Epub 2017 May 23.

PMID:
28474737
21.

Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases.

Nabeya D, Haranaga S, Parrott GL, Kinjo T, Nahar S, Tanaka T, Hirata T, Hokama A, Tateyama M, Fujita J.

BMC Infect Dis. 2017 May 2;17(1):320. doi: 10.1186/s12879-017-2430-9.

22.

Etiological analysis and epidemiological comparison among adult CAP and NHCAP patients in Okinawa, Japan.

Parrott G, Nebeya D, Kinjo T, Miyagi K, Haranaga S, Higa F, Tateyama M, Fujita J.

J Infect Chemother. 2017 Jul;23(7):452-458. doi: 10.1016/j.jiac.2017.03.018. Epub 2017 Apr 18.

PMID:
28431934
23.

The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit.

Nabeya D, Kinjo T, Parrott GL, Uehara A, Motooka D, Nakamura S, Nahar S, Nakachi S, Nakamatsu M, Maeshiro S, Haranaga S, Tateyama M, Tomoyose T, Masuzaki H, Horii T, Fujita J.

J Med Virol. 2017 Aug;89(8):1364-1372. doi: 10.1002/jmv.24800. Epub 2017 Mar 22.

PMID:
28240370
24.

Outcomes of treatment with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation.

Honda M, Sugawara Y, Watanabe T, Tateyama M, Tanaka M, Uchida K, Kawabata S, Yoshii D, Miura K, Isono K, Hayashida S, Ohya Y, Yamamoto H, Sasaki Y, Inomata Y.

Hepatol Res. 2017 Oct;47(11):1147-1154. doi: 10.1111/hepr.12853. Epub 2017 Jan 17.

PMID:
28002876
25.

An Epidemiological Analysis of Summer Influenza Epidemics in Okinawa.

Sunagawa S, Iha Y, Taira K, Okano S, Kinjo T, Higa F, Kuba K, Tateyama M, Nakamura K, Nakamura S, Motooka D, Horii T, Parrott GL, Fujita J.

Intern Med. 2016;55(24):3579-3584. Epub 2016 Dec 15. Review.

26.

Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.

Suwa Y, Suzuki N, Soga T, Harada R, Shibui A, Kuroda H, Izumi R, Tateyama M, Nakashima I, Sonoo M, Aoki M.

Intern Med. 2016;55(23):3521-3524. Epub 2016 Dec 1.

27.

Evaluation of the Lipid Concentrations after Switching from Antiretroviral Drug Tenofovir Disoproxil Fumarate/Emtricitabine to Abacavir Sulfate/Lamivudine in Virologically-suppressed Human Immunodeficiency Virus-infected Patients.

Arae H, Tateyama M, Nakamura H, Tasato D, Kami K, Miyagi K, Maeda S, Uehara H, Moromi M, Nakamura K, Fujita J.

Intern Med. 2016;55(23):3435-3440. Epub 2016 Dec 1.

28.

Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients.

Setoyama H, Tanaka M, Nagumo K, Naoe H, Watanabe T, Yoshimaru Y, Tateyama M, Sasaki M, Watanabe H, Otagiri M, Maruyama T, Sasaki Y.

J Gastroenterol. 2017 Jun;52(6):754-765. doi: 10.1007/s00535-016-1281-2. Epub 2016 Nov 21.

29.

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.

Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Higuchi I, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M.

Orphanet J Rare Dis. 2016 Nov 8;11(1):146.

30.

Tardily accelerated neurologic deterioration in two-step thallium intoxication.

Kuroda H, Mukai Y, Nishiyama S, Takeshita T, Tateyama M, Takeda A, Aoki M.

J Clin Neurosci. 2016 Dec;34:234-236. doi: 10.1016/j.jocn.2016.09.003. Epub 2016 Sep 28.

PMID:
27692615
31.

Long-term Treatment of Teicoplanin for Methicillin-resistant Staphylococcus aureus Sternal Osteomyelitis with Renal Impairment: A Case of High Teicoplanin Trough Levels Maintained by Therapeutic Drug Monitoring.

Shiohira H, Nakamatsu M, Kise Y, Higa F, Tateyama M, Hokama N, Kuniyoshi Y, Ueda S, Nakamura K, Fujita J.

Yakugaku Zasshi. 2016;136(9):1313-7. doi: 10.1248/yakushi.15-00296.

32.

Prominent sensory involvement in a case of familial amyotrophic lateral sclerosis carrying the L8V SOD1 mutation.

Nishiyama A, Warita H, Takahashi T, Suzuki N, Nishiyama S, Tano O, Akiyama T, Watanabe Y, Takahashi K, Kuroda H, Kato M, Tateyama M, Niihori T, Aoki Y, Aoki M.

Clin Neurol Neurosurg. 2016 Nov;150:194-196. doi: 10.1016/j.clineuro.2016.08.008. Epub 2016 Aug 6. No abstract available.

PMID:
27543311
33.

A mismatch between MRI lesions and SPECT hypoperfusion in tacrolimus-related encephalopathy.

Shijo T, Nishiyama S, Mukai Y, Tateyama M, Kuroda H, Aoki M.

J Neurol Sci. 2016 Aug 15;367:308-10. doi: 10.1016/j.jns.2016.06.037. Epub 2016 Jun 17. No abstract available.

PMID:
27423609
34.

Pseudo-perifascicular atrophy in the healing phase of Jo-1 antisynthetase syndrome.

Tateyama M, Shibuya S, Sato H, Fujihara K, Aoki M.

Neuromuscul Disord. 2016 Aug;26(8):521-2. doi: 10.1016/j.nmd.2016.06.003. Epub 2016 Jun 7. No abstract available.

PMID:
27321928
35.

Stabilizing effects of G protein on the active conformation of adenosine A1 receptor differ depending on G protein type.

Tateyama M, Kubo Y.

Eur J Pharmacol. 2016 Oct 5;788:122-131. doi: 10.1016/j.ejphar.2016.06.025. Epub 2016 Jun 16.

PMID:
27321872
36.

Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing.

Izumi R, Niihori T, Takahashi T, Suzuki N, Tateyama M, Watanabe C, Sugie K, Nakanishi H, Sobue G, Kato M, Warita H, Aoki Y, Aoki M.

Neurol Genet. 2015 Dec 10;1(4):e36. doi: 10.1212/NXG.0000000000000036. eCollection 2015 Dec.

37.

Isolated inclusion body myopathy caused by a multisystem proteinopathy-linked hnRNPA1 mutation.

Izumi R, Warita H, Niihori T, Takahashi T, Tateyama M, Suzuki N, Nishiyama A, Shirota M, Funayama R, Nakayama K, Mitsuhashi S, Nishino I, Aoki Y, Aoki M.

Neurol Genet. 2015 Sep 24;1(3):e23. doi: 10.1212/NXG.0000000000000023. eCollection 2015 Oct.

38.

Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.

Suda G, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kobayashi T, Shinada K, Tateyama M, Konno J, Tsukuda Y, Yamasaki K, Kimura M, Umemura M, Izumi T, Tsunematsu S, Sato F, Terashita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.

J Gastroenterol. 2016 Jul;51(7):733-40. doi: 10.1007/s00535-016-1162-8. Epub 2016 Jan 14.

39.

A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis.

Ogawa S, Hachiya A, Hosaka M, Matsuda M, Ode H, Shigemi U, Okazaki R, Sadamasu K, Nagashima M, Toyokawa T, Tateyama M, Tanaka Y, Sugiura W, Yokomaku Y, Iwatani Y.

AIDS Res Hum Retroviruses. 2016 Mar;32(3):284-9. doi: 10.1089/AID.2015.0304. Epub 2015 Dec 1.

PMID:
26528581
40.

Recurrent cerebral infarction synchronous with menorrhagia caused by endometrial stromal sarcoma.

Akaishi T, Kuroda H, Tateyama M, Yoshida Y, Otsuki T, Watanabe M, Yaegashi N, Aoki M.

J Neurol Sci. 2015 Nov 15;358(1-2):509-11. doi: 10.1016/j.jns.2015.09.367. Epub 2015 Sep 28. No abstract available.

PMID:
26432578
41.

Falciparum Malaria Incidentally Pretreated with Azithromycin.

Shibahara D, Kinjo T, Nishiyama N, Kami W, Nabeya D, Haranaga S, Higa F, Tateyama M, Shinzato T, Toma H, Kishimoto H, Fujita J.

Intern Med. 2015;54(19):2513-6. doi: 10.2169/internalmedicine.54.5399. Epub 2015 Oct 1.

42.

An Autopsy Case of Two Distinct, Acquired Drug Resistance Mechanisms in Epidermal Growth Factor Receptor-mutant Lung Adenocarcinoma: Small Cell Carcinoma Transformation and Epidermal Growth Factor Receptor T790M Mutation.

Furugen M, Uechi K, Hirai J, Aoyama H, Saio M, Yoshimi N, Kinjo T, Miyagi K, Haranaga S, Higa F, Tateyama M, Fujita J.

Intern Med. 2015;54(19):2491-6. doi: 10.2169/internalmedicine.54.5481. Epub 2015 Oct 1.

43.

[Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].

Akaishi T, Jin K, Kato K, Itabashi H, Misu T, Tateyama M, Iwasaki M, Aoki M, Nakasato N.

Rinsho Shinkeigaku. 2015;55(11):804-9. doi: 10.5692/clinicalneurol.cn-000740. Epub 2015 Sep 11. Japanese.

PMID:
26369378
44.

Serologic and Virologic Studies of an Imported Dengue Case Occurring in 2014 in Okinawa, Japan.

Saito M, Tamayose M, Miyagi K, Takaragawa H, Tateyama M, Tadano M, Fujita J.

Jpn J Infect Dis. 2016;69(1):60-5. doi: 10.7883/yoken.JJID.2015.061. Epub 2015 Jun 12.

45.

Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method.

Fukubayashi K, Tanaka M, Izumi K, Watanabe T, Fujie S, Kawasaki T, Yoshimaru Y, Tateyama M, Setoyama H, Naoe H, Kikuchi K, Sasaki Y.

Cancer Med. 2015 Aug;4(8):1214-23. doi: 10.1002/cam4.476. Epub 2015 Jun 4.

46.

Dangerous misalignment of tracheostomy tube in a dystonic patient.

Tateyama M, Akaishi T, Takano R, Chida K.

BMJ Case Rep. 2015 Apr 29;2015. pii: bcr2014208169. doi: 10.1136/bcr-2014-208169. No abstract available.

47.

Changes in oxalate and some mineral concentrations of Setaria sphacelata under cutting and uncutting conditions.

Rahman MM, Tateyama M, Niimi M, Abdullah RB, Khadijah WE, Kawamura O.

Pak J Biol Sci. 2014 Apr;17(4):586-9.

PMID:
25911853
48.

Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron.

Komatsu Y, Okita K, Yuki S, Furuhata T, Fukushima H, Masuko H, Kawamoto Y, Isobe H, Miyagishima T, Sasaki K, Nakamura M, Ohsaki Y, Nakajima J, Tateyama M, Eto K, Minami S, Yokoyama R, Iwanaga I, Shibuya H, Kudo M, Oba K, Takahashi Y.

Cancer Sci. 2015 Jul;106(7):891-5. doi: 10.1111/cas.12675. Epub 2015 May 27.

49.

Heparin-responsive angiopathy in the central nervous system caused by intravascular large B-cell lymphoma.

Yoshida S, Kuroda H, Fukuhara N, Konno H, Watanabe M, Akaishi T, Tateyama M, Aoki M.

J Neurol Sci. 2015 May 15;352(1-2):117-9. doi: 10.1016/j.jns.2015.03.026. Epub 2015 Mar 23. No abstract available.

PMID:
25829082
50.

Correlations between extent of X-ray infiltration and levels of serum C-reactive protein in adult non-severe community-acquired pneumonia.

Tamayose M, Fujita J, Parrott G, Miyagi K, Maeshiro T, Hirata T, Higa F, Tateyama M, Watanabe A, Aoki N, Niki Y, Kadota J, Yanagihara K, Kaku M, Hori S, Kohno S.

J Infect Chemother. 2015 Jun;21(6):456-63. doi: 10.1016/j.jiac.2015.02.009. Epub 2015 Feb 28.

PMID:
25817351

Supplemental Content

Loading ...
Support Center